Financial reports
ARS
2023 FY
Annual report to shareholders
25 Apr 24
10-K
2023 FY
Annual report
16 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
16 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q1
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance
15 Feb 24
8-K
Ironwood Pharmaceuticals Maintains FY 2023 Financial Guidance and Announces FY 2024 Financial Guidance
8 Jan 24
8-K
Ironwood Pharmaceuticals Reports Third Quarter 2023 Results
9 Nov 23
8-K/A
Index to Financial Statements
11 Sep 23
8-K
Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance
8 Aug 23
8-K
Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares
30 Jun 23
8-K
Departure of Directors or Certain Officers
22 Jun 23
8-K
Entry into a Material Definitive Agreement
22 May 23
8-K
Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance
4 May 23
8-K
Departure of Directors or Certain Officers
11 Apr 23
Registration and prospectus
S-8
Registration of securities for employees
9 Nov 23
S-3ASR
Automatic shelf registration
9 Nov 23
SC TO-T/A
Third party tender offer statement (amended)
29 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
26 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
20 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
16 Jun 23
SC TO-T
Third party tender offer statement
31 May 23
SC TO-C
Information about tender offer
23 May 23
SC TO-C
Information about tender offer
22 May 23
SC TO-C
Information about tender offer
22 May 23
Proxies
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
DEFA14A
Additional proxy soliciting materials
22 Apr 21
DEF 14A
Definitive proxy
22 Apr 21
DEFA14A
Additional proxy soliciting materials
21 Apr 20
DEF 14A
Definitive proxy
21 Apr 20
Other
UPLOAD
Letter from SEC
6 Dec 23
CORRESP
Correspondence with SEC
30 Nov 23
UPLOAD
Letter from SEC
15 Nov 23
CT ORDER
Confidential treatment order
26 Apr 19
CT ORDER
Confidential treatment order
26 Apr 19
CT ORDER
Confidential treatment order
19 Mar 19
UPLOAD
Letter from SEC
9 May 18
CORRESP
Correspondence with SEC
2 May 18
UPLOAD
Letter from SEC
26 Apr 18
CORRESP
Correspondence with SEC
16 Apr 18